Drawing for ORTHOCELL

USPTO serial 79246526

ORTHOCELL

Reviewed by CopyMark Law Group

Reg. 6004489Status 706Registered
Filing date
Status date
Registration date
Mar 10, 2020
Examiner
O'BRIEN, JENNIFER LYNN
Law office
Historical data usage

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with ORTHOCELL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Matthew J. Stark

Matthew J. Stark PRICE HENEVELD LLP3400 Innovation Court SEP.O. Box 2567Grand Rapids, MI 49501

Goods and services

ClassDescriptionStatusFirst use
005[ Stem cells for medical purposes; collagen for medical use; biodegradable implants comprising biological material being living cells and implantable scaffolds comprising biological materials for use in guided tissue regeneration; implant materials comprising biological material being living cells and implantable scaffolds comprising biological materials for use in guided tissue regeneration in surgery; implantable materials comprising biological material being living cells and implantable scaffolds comprising biological materials for use in guided tissue regeneration; implants comprising biological material being living cells and implantable scaffolds comprising biological materials for guided tissue regeneration; surgical implants comprised of living cells; therapeutic agents, namely, therapeutic agents for tissue regeneration; therapeutic biological products, namely, biological cell cultures for medical purposes, Biological tissue grafts, Biological preparations for guided tissue regeneration; ] medical preparations for the treatment of tissue repair; guided tissue regeneration materials, namely, implants comprising biological materials being [ living cells and ] implantable scaffolds comprising biological materials; biological preparations for medical purposes for use in guided tissue regeneration for tissue repair; tissue-regenerative medical preparations for use in guided tissue regeneration of damaged tissue [ ; biological materials for medical use, namely, surgical implants comprised of living cells, Biological tissue grafts, Biological materials for medical purposes being living cells and implantable scaffolds comprising biological materials; Collagen for medical purposes, namely, collagen based scaffolding for biomechanical support and stabilisation; Cells for medical or clinical use, namely, cellular therapeutic tendon and cartilage regeneration products ]ACTIVE—
042Medical research; scientific and technological services, namely, product research and development relating to tissue regeneration products and techniques in the field of biomechanical and cellular therapeutic medical techniques; scientific research relating to biology; scientific and technological research and design services relating to biomechanical and cellular therapeutic medical techniquesACTIVE—
044Advisory services relating to medical services; [ medical services; ] medical advisory services; [ medical care services; medical health assessment services; ] medical treatment services of regeneration of damaged tissue and for tissue repair [ ; provision of medical information; provision of medical services; medical services, including those relating to biomechanical and cellular therapeutic medical techniques ]ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 7, 2026NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Oct 7, 202671AGREGISTERED-SEC.71 ACCEPTED—
Oct 5, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Sep 10, 2026ES71TEAS SECTION 71 RECEIVED—
Mar 10, 2025REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Aug 7, 2020FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jul 19, 2020FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jul 19, 2020FIMPFINAL DISPOSITION PROCESSED—
Jun 10, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Mar 10, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 24, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 24, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 20, 2019GPNXNOTIFICATION PROCESSED BY IB—
Dec 4, 2019OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 4, 2019OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Dec 4, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 15, 2019ALIEASSIGNED TO LIE—
Nov 12, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 29, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Oct 29, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 29, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 29, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 23, 2019GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Sep 23, 2019GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 23, 2019CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 9, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 9, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 9, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 2, 2019RFNTREFUSAL PROCESSED BY IB—
Feb 12, 2019RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Feb 12, 2019RFRRREFUSAL PROCESSED BY MPU—
Feb 6, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Feb 5, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 31, 2019DOCKASSIGNED TO EXAMINER—
Dec 4, 2018MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 30, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 29, 2018REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance